APIs pour la recherche et les impuretés

Please enquire for more information about 2-Amino-3H,4H,7H-pyrrolo[2,3-d]pyrimidine-4-thione including the price, delivery time and more detailed product information at the technical inquiry form on this page

2-Methyl-3-phenylprop-2-enal is a research and development impurity standard that is custom synthesized as a drug product. It is also a synthetic metabolite that has been shown to have pharmacopoeia purity. This compound has been used in the synthesis of drugs, such as corticosteroids, antibiotics, and antihistamines. 2-Methyl-3-phenylprop-2-enal has been found to be an important metabolite in studies of the metabolism of drugs in humans and animals.

Applications Labelled MDV 3100. MDV 3100 is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. MDV 3100 has also been shown to induce tumor cell apoptosis, and has no agonist activity. MDV 3100 is a candidate for the treatment of castration-resistant prostate cancer. References Scher, H.I. et al.: Lancet, 375, 1437 (2010); Bellmunt, J. et al.: Ther. Adv. Med. Oncol., 2, 189 (2010); Ryan, C.J. et al.: J. Clin. Oncol., 29, 3651 (2011);

Applications A labelled semisynthetic derivative of Paclitaxel. An antimitotic agent that promotes the assembly of micro-tubules and inhibits their de-polymerization to free tubulin. An antineoplastic. References Ringel, I., et al.: J. Natl. Cancer Inst., 83, 288 (1991), Extra, J.-M., et al.: Cancer Res., 53, 1037 (1993)